Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04857372 |
| Title | A Phase I Study of IAG933 in Patients With Advanced Mesothelioma and Other Solid Tumors |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Novartis Pharmaceuticals |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | NLD | ITA | GBR | FRA | ESP | DEU | CHE | CAN | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of California LA | Los Angeles | California | 90095 | United States | Details | |
| Uni of Chi Medi Ctr Hema and Onco | Chicago | Illinois | 60637 | United States | Details | |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | United States | Details | |
| Cleveland Clinic Foundation | Cleveland | Ohio | 44195 | United States | Details | |
| MD Anderson Cancer Center | Houston | Texas | 77030 4009 | United States | Details | |
| Novartis Investigative Site | Melbourne | Victoria | 3000 | Australia | Details | |
| Novartis Investigative Site | Montreal | Quebec | H2W 1T8 | Canada | Details | |
| Novartis Investigative Site | Villejuif | 94800 | France | Details | ||
| Novartis Investigative Site | Essen | 45147 | Germany | Details | ||
| Novartis Investigative Site | Milan | MI | 20133 | Italy | Details | |
| Novartis Investigative Site | Rozzano | MI | 20089 | Italy | Details | |
| Novartis Investigative Site | Chuo Ku | Tokyo | 104 0045 | Japan | Details | |
| Novartis Investigative Site | Rotterdam | South Holland | 3015 GD | Netherlands | Details | |
| Novartis Investigative Site | Barcelona | Catalonia | 08035 | Spain | Details | |
| Novartis Investigative Site | Zurich | 8091 | Switzerland | Details | ||
| Novartis Investigative Site | Manchester | M20 2BX | United Kingdom | Details |